- Home
- VMAR vs RDHL Comparison
VMAR vs RDHL Comparison
Compare VMAR & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- RDHL
- Stock Information
- Founded
- VMAR 1995
- RDHL 2009
- Country
- VMAR Canada
- RDHL Israel
- Employees
- VMAR N/A
- RDHL N/A
- Industry
- VMAR Marine Transportation
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- RDHL Health Care
- Exchange
- VMAR Nasdaq
- RDHL Nasdaq
- Market Cap
- VMAR 4.5M
- RDHL 3.9M
- IPO Year
- VMAR 2020
- RDHL N/A
- Fundamental
- Price
- VMAR $1.52
- RDHL $1.64
- Analyst Decision
- VMAR
- RDHL
- Analyst Count
- VMAR 0
- RDHL 0
- Target Price
- VMAR N/A
- RDHL N/A
- AVG Volume (30 Days)
- VMAR 315.4K
- RDHL 2.9M
- Earning Date
- VMAR 12-01-2025
- RDHL 09-05-2025
- Dividend Yield
- VMAR N/A
- RDHL N/A
- EPS Growth
- VMAR N/A
- RDHL N/A
- EPS
- VMAR N/A
- RDHL N/A
- Revenue
- VMAR $1,128,568.00
- RDHL $9,550,000.00
- Revenue This Year
- VMAR N/A
- RDHL $381.91
- Revenue Next Year
- VMAR $264.29
- RDHL N/A
- P/E Ratio
- VMAR N/A
- RDHL N/A
- Revenue Growth
- VMAR N/A
- RDHL 157.62
- 52 Week Low
- VMAR $1.25
- RDHL $1.06
- 52 Week High
- VMAR $53.50
- RDHL $9.00
- Technical
- Relative Strength Index (RSI)
- VMAR 39.94
- RDHL 45.25
- Support Level
- VMAR $1.48
- RDHL $1.81
- Resistance Level
- VMAR $1.70
- RDHL $1.97
- Average True Range (ATR)
- VMAR 0.10
- RDHL 0.26
- MACD
- VMAR 0.08
- RDHL -0.05
- Stochastic Oscillator
- VMAR 42.88
- RDHL 3.33
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.